Credit Suisse Ag Charles River Laboratories International, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 47,312 shares of CRL stock, worth $8.81 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

47,312

Previous 47,732 0.88%

Holding current value

$8.81 Million

Previous $11.3 Million 13.61%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$203.52 - $273.43 $85,478 - $114,840	-420 Reduced 0.88%	47,312 $12.8 Million
Q4 2023 Feb 08, 2024	SELL	$164.52 - $238.84 $142,967 - $207,551	-869 Reduced 1.79%	47,732 $11.3 Million
Q3 2023 Nov 13, 2023	BUY	$194.44 - $217.61 $336,381 - $376,465	1,730 Added 3.69%	48,601 $9.52 Million
Q2 2023 Aug 11, 2023	SELL	$183.71 - $210.25 $319,287 - $365,414	-1,738 Reduced 3.58%	46,871 $9.85 Million
Q1 2023 May 10, 2023	SELL	$191.89 - $259.92 $41,256 - $55,882	-215 Reduced 0.44%	48,609 $9.81 Million
Q4 2022 Feb 13, 2023	SELL	$197.11 - $250.07 $908,874 - $1.15 Million	-4,611 Reduced 8.63%	48,824 $10.6 Million
Q3 2022 Nov 10, 2022	SELL	$182.44 - $250.54 $6,750 - $9,269	-37 Reduced 0.07%	53,435 $10.5 Million
Q2 2022 Aug 12, 2022	SELL	$204.13 - $302.4 $813,253 - $1.2 Million	-3,984 Reduced 6.93%	53,472 $11.4 Million
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $297,413 - $421,496	-1,164 Reduced 1.99%	57,456 $16.3 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $4.45 Million - $5.68 Million	-12,667 Reduced 17.77%	58,620 $22.1 Million
Q3 2021 Nov 12, 2021	BUY	$372.64 - $458.3 $4.23 Million - $5.2 Million	11,355 Added 18.95%	71,287 $29.4 Million
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $693,652 - $876,350	-2,358 Reduced 3.79%	59,932 $22.3 Million
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $4.5 Million - $5.39 Million	-18,013 Reduced 22.43%	62,290 $18.1 Million
Q4 2020 Feb 12, 2021	SELL	$222.0 - $252.62 $311,688 - $354,678	-1,404 Reduced 1.72%	80,303 $20.1 Million
Q3 2020 Nov 13, 2020	BUY	$175.56 - $226.45 $5.45 Million - $7.03 Million	31,047 Added 61.29%	81,707 $18.5 Million
Q2 2020 Aug 12, 2020	SELL	$118.84 - $189.72 $6.51 Million - $10.4 Million	-54,812 Reduced 51.97%	50,660 $8.83 Million
Q1 2020 May 13, 2020	BUY	$98.9 - $178.34 $5.91 Million - $10.7 Million	59,766 Added 130.76%	105,472 $13.3 Million
Q4 2019 Feb 12, 2020	BUY	$126.05 - $152.76 $394,032 - $477,527	3,126 Added 7.34%	45,706 $6.98 Million
Q3 2019 Nov 12, 2019	SELL	$125.07 - $143.67 $909,383 - $1.04 Million	-7,271 Reduced 14.59%	42,580 $5.64 Million
Q2 2019 Aug 14, 2019	SELL	$123.4 - $148.55 $607,251 - $731,014	-4,921 Reduced 8.98%	49,851 $7.07 Million
Q1 2019 May 14, 2019	BUY	$104.82 - $146.73 $922,625 - $1.29 Million	8,802 Added 19.15%	54,772 $7.96 Million
Q4 2018 Feb 13, 2019	SELL	$105.09 - $137.23 $456,090 - $595,578	-4,340 Reduced 8.63%	45,970 $5.2 Million
Q3 2018 Nov 13, 2018	SELL	$112.11 - $134.54 $2.56 Million - $3.07 Million	-22,850 Reduced 31.23%	50,310 $6.77 Million
Q2 2018 Aug 14, 2018	BUY	$102.37 - $117.25 $1.04 Million - $1.19 Million	10,120 Added 16.05%	73,160 $8.21 Million
Q1 2018 May 15, 2018	SELL	$98.19 - $115.2 $4.52 Million - $5.31 Million	-46,057 Reduced 42.22%	63,040 $6.73 Million
Q4 2017 Feb 14, 2018	SELL	$100.43 - $118.09 $911,502 - $1.07 Million	-9,076 Reduced 7.68%	109,097 $11.9 Million
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $3.74 Million - $4.23 Million	38,700 Added 48.7%	118,173 $12.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	79,473	79,473 $8.04 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.47B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account